{"nct_id":"NCT00743795","title":"Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection","status":"COMPLETED","status_verified_date":"2013-10","start_date":"2008-10","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}